Skip to content

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05879133
Enrollment
30
Registered
2023-05-30
Start date
2023-05-17
Completion date
2027-07-03
Last updated
2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lymphocytic Leukemia

Brief summary

To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.

Detailed description

Primary Objective: --Evaluate the impact of an organized, longitudinal, diet and exercise training program on fatigue as assessed by the Functional Assessment of Cancer Therapy (FACT) score in patients with CLL. Secondary Objectives: --Assess changes in physical activity, dietary behavior, physical function using the PROMIS physical function questionnaire and performance tests of physical function, body mass index (BMI) and global quality of life. Additionally, we will assess changes in fecal microbiome composition, metabolic parameters including a comprehensive lipid panel, glucose, insulin, TNF alpha, IL6, leptin, resistin, adiponectin, IGF1 and IGFBP1 and immunologic function as assessed by T cell and monocyte phenotypic and functional assays in patients with CLL after participation in the behavioral intervention. Exploratory Objectives: \-- Identify differences in the metabolic, immunologic and fecal microbiome composition in patients with CLL who have a high CLL comorbidity index score (CLL-CI) compared to patients with CLL and a low CLL-CI score. And, investigate the association of comorbidity score, disease features, CLL-specific prognostic factors and clinical outcomes.

Interventions

BEHAVIORALQuestionnaires

Survey

OTHERFit Bit

measures physical activity

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
CLL Global Research Foundation
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adults age 18-85 years of age with a histologically confirmed diagnosis of CLL and the ability to provide signed informed consent. * Self-reported physical activity will be assessed prior to enrollment and patients with a physical activity level below the level prescribed in our study will be eligible for inclusion.

Exclusion criteria

* Other active malignancy within 1 year of study enrollment (excluding non-melanoma skin cancer) * Richter's transformation, another medical condition which would prevent safe participation in the behavioral intervention * Major surgery within 1 month of enrollment * Non-English speakers * Cognitively impaired adults * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy (FACT) questionnaires.through study completion; an average of 1 year.Score Scale ranges (0-4) 0-Not at all 1-A little bit 3-Somewhat 4-Quite a bit 5-Very much

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAlessandra Ferrajoli, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 19, 2026